Research & Development

In recent years scientific breakthrough by Karyopham's founders and collborators shed more light on the role of the nuclear pore complex and the karyopherins (cyto-nuclear shuttling proteins) in many pathologies including cancer, viral infection and inflammation. An understanding of how the complex works could lead to treatments for these diseases. To learn more about Karyopharm's drug discovery platform please contact Dr. Sharon Shacham at .